Log In
Print
BCIQ
Print
Print this Print this
 

narnatumab (IMC-RON8)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionAntibody against macrophage-stimulating 1-receptor (RON)
Molecular Target Macrophage stimulating 1 receptor c-Met-related tyrosine kinase (MST1R) (RON) (CD136)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today